blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0389995

EP0389995 - Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  04.04.1996
Database last updated on 05.10.2024
Most recent event   Tooltip04.04.1996No opposition filed within time limitpublished on 22.05.1996 [1996/21]
Applicant(s)For all designated states
NISSHIN FLOUR MILLING CO., LTD.
19-12, Nihonbashi-koami-cho
Chuo-ku, Tokyo 103 / JP
[1990/40]
Inventor(s)01 / Tadokoro, Toyohiro
23-16, Midorigaoka 2-chome, Ohi-machi
Iruma-gun, Saitama-ken / JP
02 / Sato, Kiyoshi
18-23, Matsugaoka 5-chome, Tsurugashima-machi
Iruma-gun, Saitama-ken / JP
03 / Hatakeyama, Shigeki
95-1, Ohaza-Naema, Ohi-machi
Iruma-gun, Saitama-ken / JP
04 / Kawase, Shigeo
28-5, Suneore-cho 2-chome, Tsurugashima-machi
Iruma-gun, Saitama-ken / JP
05 / Ueno, Masao
37-5, Nakaarai 4-chome
Tokorozawa-shi, Saitama-ken / JP
[1990/40]
Representative(s)Gille Hrabal Partnerschaftsgesellschaft mbB Patentanwälte
Brucknerstraße 20
40593 Düsseldorf / DE
[N/P]
Former [1990/40]Türk, Gille, Hrabal, Leifert
Brucknerstrasse 20
D-40593 Düsseldorf / DE
Application number, filing date90105606.924.03.1990
[1990/40]
Priority number, dateJP1989007386628.03.1989         Original published format: JP 7386689
JP1989024230320.09.1989         Original published format: JP 24230389
[1990/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0389995
Date:03.10.1990
Language:EN
[1990/40]
Type: A3 Search report 
No.:EP0389995
Date:30.10.1991
Language:EN
[1991/44]
Type: B1 Patent specification 
No.:EP0389995
Date:31.05.1995
Language:EN
[1995/22]
Search report(s)(Supplementary) European search report - dispatched on:EP12.09.1991
ClassificationIPC:A61K31/47, A61K31/05, A61K31/08
[1990/40]
CPC:
A61K31/47 (EP,US)
Designated contracting statesDE,   DK,   ES,   FR,   GB,   IT,   SE [1990/40]
TitleGerman:Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie[1990/40]
English:Isoquinoline derivatives for the treatment of glaucoma or ocular hypertension[1990/40]
French:Dérivés de l'isoquinoléine pour le traitement de glaucome ou de l'hypertension oculaire[1990/40]
Examination procedure16.04.1992Examination requested  [1992/25]
29.11.1993Despatch of a communication from the examining division (Time limit: M04)
09.04.1994Reply to a communication from the examining division
14.07.1994Despatch of communication of intention to grant (Approval: Yes)
06.10.1994Communication of intention to grant the patent
31.12.1994Fee for grant paid
31.12.1994Fee for publishing/printing paid
Opposition(s)01.03.1996No opposition filed within time limit [1996/21]
Fees paidRenewal fee
20.03.1992Renewal fee patent year 03
26.03.1993Renewal fee patent year 04
28.03.1994Renewal fee patent year 05
23.03.1995Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XD]US4129565  (FUKUSHIMA HIDEO, et al);
 [XD]GB2101990  (NISSHIN FLOUR MILLING CO [JP]);
 [Y]EP0113910  (NISSHIN FLOUR MILLING CO [JP]);
 [Y]FR2447721  (OTSUKA PHARMA CO LTD [JP])
 [X]  - CHEMICAL ABSTRACTS, vol. 108, no. 19, 9th May 1988, page 52, abstract no. 161296q, Columbus, Ohio, US; S. KOHDA et al.: "An ocular toxicity study of (+)-4-(3-tert-butylamino-2-hydroxypropoxy)-2-methyl-1(2H)-isoquinolinone hydrochloride (N-969), a beta-adrenergic blocking agent, in beagle dogs: oral administration for 26 weeks", & OYO YAKURI 1987, 34(6), 553-67
 [A]  - Ph. DOROSZ: "Guide pratique des médicaments", 7th edition, 1987, pages 818-819, Maloine S.A., Paris, FR
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.